Table 1.
Recent applications of arrays in infection and immunity
Array format | Biomarker discovery | Diagnostic profiles | Vaccine candidates | Surveillance/epidemiology | Number of unique elementsa |
---|---|---|---|---|---|
DNA | – | [7, 15••, 19, 22, 49] | – | [15••, 20•, 24•, 27•] | 55–22 000 |
Antigen/ORFeome | [51, 55, 57•] | [52, 54, 56•, 58••, 124] | [50, 125] | – | 22–232 |
pMHC | [65•, 66] | – | [67••] | – | 7 |
Glycan | – | [79, 91•, 97, 126] | [80•, 81•, 90, 93, 127] | [95••] | 9–200 |
Lectin | – | [105] | – | – | 9–21 |
Refers to the number of unique elements (e.g. DNA oligonucleotides) individually produced and immobilized on the array.